Extending our understanding of exenatide: a rare case of angio-oedema
Sign Up to like & getrecommendations! Published in 2021 at "BMJ Case Reports"
DOI: 10.1136/bcr-2020-235663
Abstract: Exenatide is a subcutaneous injectable glucagon-like peptide 1 receptor agonist that has been approved by the Federal Drug Administration for the treatment of type 2 diabetes mellitus. While side effects such as nausea, vomiting and… read more here.
Keywords: understanding exenatide; extending understanding; angio oedema; case ... See more keywords